E. Mansour

Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study.

R. Gray, C. Osborne, D. Tormey, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduced-intensity therapy of pediatric lymphoblastic leukemia: Impact of residual disease early in remission induction.

R. Ribeiro, E. Coustan-Smith, W. Rashed, 2020, Blood.